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Abstract Understanding the mechanisms by which cyto-
chrome(s) P450 (CYP) discriminate good from poor substrates,
and orient them for highly regio- and stereoselective oxidation,
has considerable intrinsic and practical importance. Here we
present results of a study of fatty acid hydroxylation by CYP2B1
in a reconstituted system and in microsomes from phenobarbital-
pretreated rats. The results indicate that 2B1 prefers decanoic
acid as the optimum fatty acid substrate (among C8^C16) and
that it hydroxylates all positions five or more methylene groups
distant from the carboxylate carbon. That hydroxylation does
not occur at carbon atoms closer to the carboxyl group than the
C6 position suggests that these carbons may not reach the ferryl
oxygen because the carboxyl group is anchored to a specific site
at a fixed distance from the heme iron. ß 2002 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Understanding the mechanisms by which di¡erent cyto-
chrome P450 (CYP) isozymes discriminate good from poor
substrates, and orient them for highly regio- and stereoselec-
tive oxidation, has considerable intrinsic and practical impor-
tance. We have been interested in elucidating the basis for the
pronounced substrate- and regioselectivity of CYP4A en-
zymes, especially CYP4A1. This isozyme accepts only fatty
acids or closely related aliphatic analogs as substrates, exhibits
a strong preference for a C12 chain length and hydroxylates
the g-terminal methyl group with high regioselectivity. A fu-
sion protein (f4A1) containing the elements of P450 reductase
and CYP4A1 shows identical characteristics and has been
probed in our laboratory using more than 40 fatty acid ana-
logs of varying chain length, steric bulk, conformational ri-
gidity and chemical functionality [1^4]. The results have sug-
gested that the enzyme has a speci¢c polar group recognition
site (for COO3, CH2OH, etc.) located the length of an ex-
tended C12 chain from the heme iron, and a moderately con-
gested hydroxylation site, such that g-methyl groups (even
those of a t-butyl group) can approach the ferryl oxygen
and become hydroxylated, whereas mid-chain methylene
groups, regardless of chain length, do so only with great dif-
¢culty. A related situation exists for the bacterial fatty acid
hydroxylase CYP102, which preferentially hydroxylates longer
chains (C16^C18) at positions g-1, g-2 and g-3 but not g.
Here, polar group recognition is provided by R47 while F87
blocks the g-methyl from accessing the ferryl group [5].
Several other mammalian CYPs also hydroxylate fatty
acids. For example, CYP2E1, which is well known to oxidize
a wide variety of small molecules (e.g. acetaminophen and
smaller), hydroxylates fatty acids almost exclusively at the
g-1 position and shows a pronounced preference for undeca-
noic and lauric acids as substrates and similarly sized aliphatic
alcohols and ketones as inhibitors [6^10,25]. Interestingly, the
T303S mutant of 2E1 shows similar chain length preference
but dramatically reduced regioselectivity, forming a series of
monohydroxy metabolites from g to g-4 [11,12]. CYP2C2
from rabbit liver hydroxylates fatty acids primarily at the g
and g-1 positions and nonanoic acid has the optimum chain
length [12]. Little else is known about the substrate speci¢city
of this isozyme, but many other 2C enzymes hydroxylate larg-
er highly non-planar molecules such as steroids, sedative hyp-
notics, tolbutamide and sulfonamides. CYP2B1, which ac-
counts for v 75% of the P450 content of microsomes from
phenobarbital (PB)-pretreated rats, is well known for accept-
ing a broad array of highly non-planar medium-sized mole-
cules ranging from adamantane to hexobarbital as substrates
[13].
In this manuscript we present results of a study of fatty acid
hydroxylation by CYP2B1 in puri¢ed reconstituted form and
in microsomes from PB-pretreated rats. The results indicate
that CYP2B1 prefers decanoic acid as the optimum fatty acid
substrate (among C8^C16) and that it hydroxylates all posi-
tions ¢ve or more methylene groups distant from the carbox-
ylate carbon. That hydroxylation does not occur at carbon
atoms closer to the carboxyl group than the C6 position sug-
gests that these carbons may not reach the ferryl oxygen be-
cause the carboxyl group is anchored to a speci¢c site at a
¢xed distance from the heme iron.
2. Materials and methods
2.1. Preparation of microsomal fractions
Hepatic microsomes were obtained from livers of PB-treated rats by
di¡erential centrifugation as previously described [14]. Pyrophos-
phate-washed microsomes were suspended in 100 mM potassium
phosphate bu¡er, pH 7.4, containing 20% glycerol. The suspension
was divided into small aliquots and stored at 370‡C prior to use with
no subsequent loss of enzyme activity.
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2.2. Enzyme preparations
Electrophoretically homogenous CYP2B1 was isolated as described
previously [15]. NADPH-CYP oxidoreductase (OR) was kindly pro-
vided by Dr. R.W. Estabrook (University of Texas Southwestern
Medical Center at Dallas).
2.3. Enzyme assay
CYP concentrations were determined by the method of Omura and
Sato using the extinction coe⁄cient O450ÿ490 = 91/mM/cm [16].
NADPH-CYP OR concentrations were measured spectrophotometri-
cally using the extinction coe⁄cient O456 = 21.4/mM/cm/ [17]. Micro-
somal protein concentrations were determined by the bicinchoninic
acid method (Pierce, Rockford, IL, USA).
2.4. Fatty acid hydroxylase assay
Identi¢cation and quantitation of metabolites were performed using
GC/MS as described previously [4]. Incubations were conducted at
37‡C in 13U100 mm glass tubes. Brie£y, reaction bu¡er (100 mM
potassium phosphate, pH 7.4, containing 10 mM MgSO4) was pre-
heated to 37‡C, and aliquots of substrate (100 nmol) and microsomes
(1.4^1.7 nmol P450), or 2B1 reconstituted system (1.0 nmol CYP2B1,
1.5 nmol OR and 50 Wg DLPC) were added. This mixture was vor-
texed and incubated for 2 min at 37‡C and the reaction started by the
addition of NADPH (1 Wmol; 20 Wl of 50 mM stock solution in H2O).
The ¢nal incubation volume was 1.0 ml. The mixtures were incubated
for 10 min at 37‡C (the reaction rate is constant for at least 12 min
[4]). After incubation, reactions were quenched with HCl and metab-
olites were recovered by solid phase extraction, derivatized with N,O-
bis(trimethylsilyl)tri£uoroacetamide and analyzed by capillary GC/
MS. For quantitation, metabolite response factors were measured
directly from standards or estimated from closely similar compounds
[18].
3. Results and discussion
We ¢rst examined the hydroxylation of nine saturated
straight-chain fatty acids (C8^C16) by liver microsomes from
PB-induced rats in which the major P450 isozyme present
(v75% of total) is CYP2B1 [19^22]. The results obtained,
presented in Table 1, show several interesting features. All
nine substrates were hydroxylated, but with widely di¡ering
e⁄ciency. Total turnover was signi¢cantly greater for the C10,
C11 and C12 substrates compared to their shorter or longer
homologs. With most substrates the hydroxylation showed
moderate to high regioselectivity for the terminal g position.
This was unexpected, considering the generally low speci¢city
of CYP2B1 toward a wide range of xenobiotic substrates.
This regioselectivity for g-hydroxylation was most pro-
nounced with decanoic and nonanoic acids, where it ac-
counted for 83% of total products. Similar results were ob-
served with nonanoic acid, and to a lesser extent with several
other acids. Given that hydroxylation of decanoic acid occurs
on every carbon from C10 through C6, the product ratio ex-
pected on purely statistical grounds would have been 3/11 or
27% g-alcohol, but if one takes into account the intrinsically
lower reactivity of methyl vs. methylene hydrogens, this num-
ber should be even lower. Thus the g-regioselectivity of
CYP2B1 toward medium-chain fatty acids is quite striking
indeed.
In addition, a second type of selectivity is revealed in the
hydroxylation data of Table 1. Thus, it appears that no hy-
droxylations occur at carbons within the ¢rst six atoms of the
fatty acid chain (counting from the carboxylate carbon as C1).
Otherwise, hydroxylation occurs at all positions to some ex-
tent. For low-turnover substrates like C15 and C16 it was not
always possible to detect every possible hydroxylation prod-
uct. These more strongly hydrophobic acids may have been
less available to the enzyme because of enhanced partitioning
into microsomal lipid or micelles.
One interpretation of the above results is that CYP2B1 has
an active center large enough to accommodate fatty acids up
to at least C14 in total size, probably in a coiled rather than
extended conformation, but with the side chains having the
conformational freedom to present most or all of the methyl-
ene positions to the ferryl oxygen. Thus, for longer fatty acids
a larger array of regioisomeric alcohol metabolites is pro-
duced. The absence of hydroxylation on the ¢rst six carbons
of the molecule in all cases may indicate that the carboxylate
group is recognized and bound at a site that is located about
the length of a pentamethylene chain away from the ferryl
oxygen, a situation not unlike that inferred for CYP4A1 [2^
4] or observed for CYP102 [5]. Such a view is also consistent
with the broad acceptance of many medium-sized non-planar
xenobiotics as substrates and/or ligands by CYP2B1.
In reconstituted systems, puri¢ed CYP2B1 showed a some-
what similar pattern of selectivity toward fatty acid substrates
(Table 2). However, in these experiments, the turnover num-
bers were lower that those observed with microsomes because
we did not attempt to optimize the reconstitution conditions
in terms of lipid, detergent, reductase, cytochrome b5, etc.
Variation of these factors in reconstituted systems is well
known to a¡ect turnover rates. One consequence of the lower
overall turnover rates is that it became di⁄cult to observe
many of the individual minor mid-chain hydroxylation prod-
ucts that were observed in the microsomal system. Neverthe-
less, with reconstituted CYP2B1, decanoic acid was again hy-
droxylated preferentially at the g position, and nonanoic acid,
the shortest acid studied, was a decidedly poorer substrate
overall. With longer fatty acids this preference for g-hydrox-
Table 1
Fatty acid hydroxylation by PB-induced microsomes
Fatty acid Metabolite produced (pmol product/min/nmol P450)
g g-1 g-2 g-3 g-4 g-5 g-6 Total
Octanoic 56 þ 12 20 þ 3 42 þ 19 nd nd nd nd 118 þ 34
Nonanoic 268 þ 18 51 þ 9 32 þ 8 nd nd nd nd 351 þ 35
Decanoic 1173 þ 394 88 þ 44 45 þ 19 70 þ 24 32 þ 2 nd nd 1409 þ 484
Undecanoic 562 þ 206 303 þ 54 75 þ 9 91 þ 17 61 þ 13 21 þ 3 nd 1113 þ 301
Dodecanoic 542 þ 284 592 þ 220 163 þ 64 107 þ 41 61 þ 24 27 þ 12 21 þ 1 1514 þ 645
Tridecanoic 194 þ 104 241 þ 47 57 þ 3 70 þ 14 nd 18 þ 3 20 þ 2 600 þ 173
Tetradecanoic 140 þ 53 118 þ 5 46 þ 10 55 þ 13 26 þ 8 24 þ 4 19 þ 1 429 þ 88
Pentadecanoic 81 þ 16 120 þ 6 nd nd nd nd nd 201 þ 22
Hexadecanoic 82 þ 46 41 þ 16 nd nd nd nd nd 122 þ 62
All values are reported as the mean from four to six experiments þ S.D. nd, not detected. Our level of detection was less than 14 pmol/min/
nmol P450
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ylation was signi¢cantly reduced or even shifted to the g-1
position. In contrast, with CYP4A1, the strong preference for
g-hydroxylation is maintained for longer fatty acids, even
though their turnover decreases signi¢cantly [1].
It is well documented that CYP2B1 displays very broad
substrate speci¢city and its active center can accommodate a
wide variety of di¡erent chemical structures. CaJacob et al.
[23] reported P450b (‘major’ form of PB-induced rat CYP) to
have g/g-1 ratio for hydroxylation of lauric acid of 1:8 (0.13),
while in PB-microsomes Okita and Masters reported this ratio
as 0.6 [24]. We have found that for lauric acid (C12) the g/g-1
ratio for both microsomal and reconstituted CYP2B1 is
around 1 (Table 1). While microsomal data on the hydroxy-
lation ratio of lauric acid can be considered as roughly sim-
ilar, the di¡erence in the data concerning the reconstituted
system is considerable. CaJacob et al. [23] used in their study
PB-induced CYP isolated by the procedure of Waxman and
Walsh [25]. Analysis of the N-terminal sequence from this
paper revealed that this protocol leads to the isolation of
CYP2B2 rather than CYP2B1.
The site of hydroxylation in a fatty acid substrate is appar-
ently determined by the interplay of two factors, one intrinsic
to the substrate molecules (thermodynamic), and one intermo-
lecular in nature (steric). The thermodynamic factor (i.e.
weaker C^H bonds in methylene vs. methyl groups) strongly
favors g-1 hydroxylation; thus, g-hydroxylation occurs when
the fatty acid is placed in the active center in such a way that
only the g-methyl group can ‘reach’ ferryl oxygen of P450
heme. By this means, analysis of chain-length dependence
with regard to regioselectivity of fatty acid hydroxylation
can reveal information about the structure of active center
and the distance between entrance to the substrate access
channel and the heme ferryl oxygen.
To date four di¡erent P450 isozymes (CYP2E1, CYP2C2,
CYP4A1 and CYP4A11) have been characterized in terms of
speci¢city toward hydroxylation of fatty acids, and all exhibit
distinct regioselectivity and chain-length dependence. While
CYP2E1 hydroxylates fatty acids almost exclusively at the
g-1 position with lauric acid being the most favorable sub-
strate, CYP2C2 hydroxylates fatty acids at di¡erent positions
depending on the chain length with nonanoic acid being pref-
erentially hydroxylated at the g position [9,12]. Remarkable
selectivity in hydroxylation of the less reactive, terminal meth-
yl group of fatty acids is a characteristic feature of CYP4A
isozymes. CYP4A isozymes primarily hydroxylate a very ho-
mogenous group of substrates, medium and long-chain fatty
acids, prostaglandins and eicosanoids.
It is quite striking that the value of the g/g-1 ratio for
microsomal CYP2B1 hydroxylation of decanoic acid is on
the same order of magnitude as g/g-1 ratio for CYP4A1
hydroxylation of lauric acid. Shortening as well as increasing
the chain length causes a sharp decrease in the g/g-1 ratio.
Taken together the data presented con¢rm and extend ear-
lier suggestions [1,26] that the characteristic feature of a P450
active center is the presence of a polar recognition site that
can govern positioning of the substrate molecule in the active
center, and in case of CYP2B1, the distance between this
polar recognition site and the oxo-heme group is approxi-
mately the length of an extended 10-carbon chain (ca. 12
Aî ). In conclusion, we would like to point out the general
applicability and ease of use of homologous series of fatty
acids and fatty acid analogs as substrates for active center
mapping of CYP isozymes.
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